PRESENTING THE FALCON AWARDS FOR DISEASE ELIMINATION

The Falcon Awards for Disease Elimination is an awards scheme that aims to help partners go further and faster towards their disease elimination goals.   

Since its inception, the Falcon Awards for Disease Elimination has evolved to tackle critical challenges in disease elimination. In 2021, GLIDE launched the inaugural Falcon Awards, supporting four recipients to advance the elimination of its four focus diseases—malaria, polio, onchocerciasis, and lymphatic filariasis in endemic countries. Building on this momentum, the 2023 edition, The Climate Edit, supported formative research to explore the intersection of climate change and infectious diseases. Nine winners were selected, and their six-month research findings were released around COP28, contributing valuable insights to the field. In 2024, GLIDE introduced the Western Pacific edition of the Falcon Awards, aimed at driving disease elimination efforts in the region. Five formative research projects and one advocacy initiative were awarded to conduct six-month projects, strengthening efforts to combat infectious diseases across the Western Pacific. Collectively, these editions of the Falcon Awards demonstrate GLIDE’s ongoing commitment to generating evidence through innovation, fostering collaboration, and advancing context-specific strategies for disease elimination.  

falcon_main1

ABOUT THE FALCON AWARDS – THE INTEGRATION EDIT

falcon_main2

While significant progress is being made in eliminating preventable infectious diseases, efforts are often designed and implemented through vertical, disease-specific programs. This approach can lead to inefficiencies, duplication of efforts, and missed opportunities for collaboration — particularly in regions where multiple diseases co-exist and health systems are stretched.  

More research is needed to demonstrate whether, how, and where integrated approaches can improve health outcomes, strengthen systems, and accelerate elimination efforts. Advocacy is essential to drive engagement, mobilize resources, and shape policies for sustained impact.  That’s why this year, the Falcon Awards is seeking to catalyze new ways of working by supporting projects that test new approaches, generate evidence, and advocate for integration, fostering collaboration across diseases, sectors, and borders. 

Aim of the awards 

The aim of the 2025 awards is to advance the body of knowledge and evidence for integrated approaches for the elimination of infectious diseases. Through these awards, GLIDE is accepting concept proposals for research projects and advocacy initiatives that (upon selection) will be co-created with GLIDE, meaning selected applicants will have the opportunity to collaboratively refine and develop full project plans with the GLIDE team. All concepts should aim to meet one or more of the following objectives: 

  1. Generating evidence and testing approaches to advance the elimination of infectious diseases through integrated approaches. 
  2. Disseminating knowledge to enhance understanding and catalyse action for integrated disease elimination strategies. 
  3. Supporting local or regional advocacy efforts to advance integrated approaches to disease elimination. 
  4. Raising awareness of and for integrated disease elimination strategies and approaches. 
  5. Cultivating partnerships aimed at advancing elimination through integrated approaches that enhance knowledge or evidence around the transmission, control, elimination, and eradication of infectious diseases. 

AWARDS STRUCTURE

The Falcon Awards have a total funding envelope of up to US$2.4 million, allocated across two key categories: Research and Advocacy. Funding is awarded to winning concepts on a tiered basis, with longer-duration projects eligible for higher grant amounts. Please note that the total award amount will depend on the final, agreed project plan developed in collaboration with GLIDE.  

ELIGIBILITY

Applications must come from within an organization or entity with demonstrated experience in disease elimination. The following entities are eligible to apply: 

  1. National or regional academic or research institutions 
  2. Government entities 
  3. Public, private, or non-governmental sector institutions 
  4. Consortia, coalitions, or networks may apply but must meaningfully include either an academic institution, Civil Society Organization (CSO), or Non-Governmental Organizations (NGO). 
  5. Early career researchers 

Thematic Scope  

This year’s Falcon Awards is accepting concepts that aim to advance integrated elimination strategies for infectious diseases that are cross-border, cross-sector, or cross-disease. Concepts may focus on, but are not limited to, the following sub-categories:   

  1. Pilot field projects on the integration of eliminable diseases 
  2. Mainstreaming eliminable diseases into national health systems 
  3. “Sustaining elimination” Post Validation Surveillance/preventing reintroduction 
  4. Community-centered approaches to disease elimination 
  5. One Health approaches to disease elimination 
  6. Innovative approaches to disease elimination 
  7. Investment cases for disease elimination 

  • 7 APRIL Open for Submissions
  • 7 MAY Close for Submissions
  • SUMMER 2025 Co-development and Finalization of Project Design
  • SEPTEMBER 2025 Winners Announcement

SUBMISSIONS
ARE OPEN ScribbleBtm

Contact support: falconawards@glideae.org

DSC0539

"I am delighted to announce GLIDE’s 4th iteration of the Falcon Awards for Disease Elimination. This year, the focus is on integration and will support innovative research and advocacy initiatives to drive collaborative, cooperative and coordinated approaches for disease elimination. By fostering collaboration and generating critical evidence, we can inform policies and strengthen health systems to accelerate and sustain progress and create lasting change." Scribble-04

Simon Bland, CEO, GLIDE

MORE INITIATIVES Scribble-22